**Core Concept**
The cardiotoxicity of local anesthetics is primarily due to their ability to block sodium channels, leading to a decrease in the excitability of cardiac cells. This can result in a range of cardiac complications, from mild bradycardia to severe arrhythmias and cardiac arrest.

**Why the Correct Answer is Right**
Bupivacaine is considered the most cardiotoxic local anesthetic due to its high lipid solubility, which allows it to easily penetrate the cardiac cell membrane and bind to sodium channels. This can lead to a rapid decrease in cardiac excitability, resulting in severe arrhythmias and cardiac arrest. The high potency and lipid solubility of bupivacaine make it more likely to cause cardiac toxicity, especially in cases of accidental intravascular injection.

**Why Each Wrong Option is Incorrect**
**Option A:** (Lidocaine) While lidocaine is also a local anesthetic, it is less cardiotoxic than bupivacaine and is actually used to treat certain types of arrhythmias. Its lower lipid solubility and higher clearance rate make it less likely to cause cardiac toxicity.

**Option B:** (Ropivacaine) Ropivacaine is a newer local anesthetic that is designed to be less cardiotoxic than bupivacaine. It has a lower lipid solubility and a more favorable pharmacokinetic profile, making it a safer choice for regional anesthesia.

**Option C:** (Mepivacaine) Mepivacaine is another local anesthetic that is less cardiotoxic than bupivacaine. While it is still a potent local anesthetic, its lower lipid solubility and higher clearance rate make it less likely to cause cardiac toxicity.

**Option D:** (Procaine) Procaine is an older local anesthetic that is less potent and less cardiotoxic than bupivacaine. Its lower lipid solubility and shorter duration of action make it less likely to cause cardiac toxicity.

**Clinical Pearl / High-Yield Fact**
In cases of suspected local anesthetic systemic toxicity, immediate recognition and treatment are critical. This includes stopping the infusion, administering oxygen, and using cardiopulmonary resuscitation (CPR) as needed. The American Society of Regional Anesthesia and Pain Medicine (ASRA) recommends the use of lipid emulsion therapy in cases of severe local anesthetic systemic toxicity.

**Correct Answer: B. Bupivacaine**